Select Page

NEW YORK, Sept. 03, 2020 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Odonate Therapeutics, Inc. (“Odonate” or the “Company”) (NASDAQ: ODT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.